Compare MCFT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCFT | NPCE |
|---|---|---|
| Founded | 1968 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 604.0M | 536.6M |
| IPO Year | 2015 | 2021 |
| Metric | MCFT | NPCE |
|---|---|---|
| Price | $25.12 | $16.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $24.25 | $18.33 |
| AVG Volume (30 Days) | 138.5K | ★ 168.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $284,203,000.00 | $99,986,000.00 |
| Revenue This Year | $9.18 | $0.90 |
| Revenue Next Year | $8.23 | $24.46 |
| P/E Ratio | $77.12 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $17.19 | $7.56 |
| 52 Week High | $28.44 | $19.60 |
| Indicator | MCFT | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 55.86 |
| Support Level | $21.90 | $15.25 |
| Resistance Level | $26.49 | $16.96 |
| Average True Range (ATR) | 0.94 | 0.68 |
| MACD | 0.33 | 0.10 |
| Stochastic Oscillator | 88.30 | 68.47 |
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.